Table 3.
Comparing clinical characteristics between OHD patients and non-OHD patients from KP-PLA
Characteristic | OHD patients (n = 29) | non-OHD patients (n = 134) | P Value |
---|---|---|---|
Age, years | 67.0 (62.0-73.0) | 61.0 (51.0-70.0) | 0.053 |
Gender | 0.451 | ||
Male | 16 (55.2) | 84 (62.7) | |
Female | 13 (44.8) | 50 (37.3) | |
Underlying or concomitant conditions | |||
Diabetes mellitus | 7 (24.1) | 74 (55.2) | 0.002* |
History of intra-abdominal trauma or surgery | 26 (89.7) | 20 (14.9) | 0.000* |
Hypertension | 5 (17.2) | 45 (33.6) | 0.084 |
Malignancy | 2 (6.9) | 5 (3.7) | 0.797 |
Admission temperature (°C) | 38.0 (37.3-39.0) | 39.0 (38.0-39.5) | 0.019* |
Clinical Symptoms | |||
Fever (>37.5°C) | 20 (69.0) | 117 (87.3) | 0.030* |
Chill | 23 (79.3) | 109 (81.3) | 0.800 |
Abdominal pain | 14 (48.3) | 51 (38.1) | 0.308 |
Vomit | 4 (13.8) | 20 (14.9) | 1.000 |
Frail | 3 (10.3) | 22 (16.4) | 0.590 |
Abdominal distension | 2 (6.9) | 3 (2.2) | 0.216 |
Invasive procedure | 25 (86.2) | 116 (86.6) | 1.000 |
Use of hormones and/or immunosuppressants | 11 (37.9) | 41 (30.6) | 0.442 |
Multiplicity of the abscess | 0.409 | ||
Single | 19 (65.5) | 98 (73.1) | |
Multiple (≥2 abscesses) | 10 (34.5) | 36 (26.9) | |
Laboratory examination | |||
WBC count, ×109/L | 8.9 (5.9-11.6) | 11.1 (8.2-14.0) | 0.014* |
RBC count, ×1012/L | 3.9 (3.5-4.1) | 3.9 (3.6-4.2) | 0.667 |
ALT(U/L) | 33.0 (14.0-49.0) | 43.0 (27.0-82.8) | 0.033* |
AST(U/L) | 35.0 (26.0-50.0) | 37.0 (24.0-70.8) | 0.621 |
Albumin, g/L | 29.8±5.0 | 29.3±5.1 | 0.609 |
Method of abscess treatment | |||
Simple antibacterial | 6 (20.7) | 24 (17.9) | 0.726 |
Abscess drainage | 20 (69.0) | 109 (81.3) | 0.137 |
Surgical removal | 3 (10.3) | 1 (0.7) | 0.021* |
Prognosis of abscess | 0.233 | ||
Effective | 18 (62.1) | 98 (73.1) | |
Ineffective | 11 (37.9) | 36 (26.9) | |
Metastatic infections | 1.000 | ||
Endophthalmitis | 0 (0.0) | 1 (0.7) | |
Cephalomeningitis | 0 (0.0) | 1 (0.7) | |
Bacterial peritonitis | 0 (0.0) | 1 (0.7) | |
Pneumonia | 0 (0.0) | 1 (0.7) | |
Clinical outcomes | |||
Length of stay in hospital, days | 23.0 (15.0-28.0) | 16.0 (12.0-25.0) | 0.045* |
Admission to ICU | 1 (3.4) | 15 (11.2) | 0.354 |
Septic shock | 3 (10.3) | 12 (9.0) | 1.000 |
Septicemia | 5 (17.2) | 15 (11.2) | 0.557 |
In-hospital deaths | 0 (0.0) | 1 (0.7) | 1.000 |
Values are presented as median (25th - 75th percentile), mean ± SD or No. (%) of patients
WBC white blood cell, RBC red blood cell, ALT alanine aminotransferase, AST aspartate aminotransferase, ICU intensive care unit *P < 0.05